Gastroenteritis Max Panel

What is it?
 The Gastroenteritis Max Panel is an advanced multiplex polymerase chain reaction (PCR) assay engineered to detect and differentiate a comprehensive range of bacterial, viral, and protozoan pathogens implicated in gastroenteritis. This panel leverages cutting-edge molecular diagnostics to identify multiple pathogens simultaneously, including those that are challenging to isolate using traditional culture methods. Its design enables the precise detection of co-infections and rare pathogens, providing critical diagnostic insights in high-complexity gastrointestinal cases. Furthermore, the Gastroenteritis Max Panel includes resistance gene profiling, facilitating evidence-based antimicrobial stewardship and mitigating risks associated with delayed or inappropriate treatment.

Target and Specimen Type

• Target Pathogens: Detects key bacterial pathogens such as Salmonella spp., Shigella spp., Campylobacter spp., and Escherichia coli (including STEC); viral agents like Norovirus, Rotavirus, and Adenovirus; and protozoan parasites such as Giardia lamblia and Cryptosporidium spp. The panel also identifies resistance markers, including those for extended-spectrum β-lactamases (blaCTX-M) and fluoroquinolone resistance (gyrA mutations).
• Specimen Types: Validated for a range of gastrointestinal specimens, including stool samples and rectal swabs, ensuring compatibility with diverse diagnostic workflows in clinical and public health settings.